Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.
In this discussion, you’ll learn:
- Strengths and weaknesses of different insight data sources from a business perspective
- How technologies like AI-supported analysis and reporting help you integrate data sources to deeply understand disease communities
- Real-world results pharma leaders are achieving by integrating data sources and applying AI-supported insights management processes

Moderator: Paul Simms
CEO Impatient Health
Medical Affairs Professional Society
Speaker: Lance Hill
CEO at Within3
Medical Affairs Professional Society
Speaker: Adam Fairfield
Senior Director of Medical Affairs Launch Excellence at Lilly
Medical Affairs Professional Society
Speaker: Tomasz Piotrowski
Clinical Innovation Champion
Medical Affairs Professional Society
Speaker: Sahar Javaherian
National Director at Jazz Pharma
Medical Affairs Professional Society
Speaker: Elena Lunina
Global Medical Omnichannel Head
Medical Affairs Professional Society